Search

Search Results for “Pfizer”

Showing results 21 - 30 of 492

• Eliquis Lawsuits - Severe Physical Injuries, Claims & Settlements

  https://www.drugwatch.com/eliquis/lawsuits/
  Bristol-Myers Squibb and Pfizer claimed the anticoagulant (blood thinner) Eliquis (apixaban) was the best in its new class of Factor Xa (an essential ...

• Plaintiffs File Motion to Create Depo-Provera MDL in California

  https://www.drugwatch.com/news/2024/12/03/plaintiffs-file-motion-to-create-depo-provera-mdl-in-california/
  Dec 3, 2024 ... ... Pfizer, even though Pfizer did not manufacture the generic versions. One prominent argument for innovator liability involves how drug labels ...

• Zantac Lawsuit: Status, Eligibility, & Settlements

  https://www.drugwatch.com/zantac/lawsuits/
  Zantac Lawsuit. Zantac lawsuits claim Zantac with NDMA-contaminated ranitidine caused people to develop cancer. Sanofi and Pfizer have offered up to $350 ...

• Chantix Recalled over Potential Cancer Risk

  https://www.drugwatch.com/news/2021/09/23/chantix-recalled-over-increased-cancer-risk/
  Sep 23, 2021 ... Pfizer said it was recalling all lots of Chantix 0.5 and 1 mg tablets because of N-nitroso-varenicline, known as a nitrosamine, found above ...

• Oxbryta Lawsuit Claims Sickle Cell Drug Caused Serious Health ...

  https://www.drugwatch.com/news/2024/11/15/oxbryta-lawsuit-claims-sickle-cell-drug-caused-serious-health-issues/
  Nov 15, 2024 ... According to the Food and Drug Administration, Pfizer's post-market clinical trials revealed a higher rate of vaso-occlusive crises in patients ...

• Viagra - Erectile Dysfunction, Side Effects, & Drug Interactions

  https://www.drugwatch.com/viagra/
  Pfizer World Headquarters. Viagra manufacturer Pfizer's world headquarters in Manhattan. Pfizer saw an economical advantage with this new discovery and ...

• FDA Warns of Heart Problems and Cancer with Arthritis Drug Xeljanz

  https://www.drugwatch.com/news/2021/04/05/fda-warns-heart-problems-cancer-xeljanz/
  Apr 5, 2021 ... According to Pfizer's Xeljanz website, the drug is the most prescribed in its class of JAK inhibitors. The FDA approved it to treat rheumatoid ...

• Depo-Provera Lawsuits Consolidated into Florida-Based MDL in ...

  https://www.drugwatch.com/news/2025/02/07/depo-provera-lawsuits-consolidated-into-florida-based-mdl-in-major-step-for-litigation/
  Feb 7, 2025 ... Pfizer, meanwhile, had suggested New York for the MDL. But the Judicial Panel on Multidistrict Litigation ultimately opted to send the 27 ...

• Why People Are Filing Oxbryta Lawsuits: A Q&A With Attorney Laura ...

  https://www.drugwatch.com/news/2025/02/06/why-people-are-filing-oxbryta-lawsuits-a-qa-with-attorney-laura-baughman/
  Feb 6, 2025 ... Plaintiffs have filed lawsuits over claims that Pfizer and Global Blood Therapeutics (GBT) failed to warn that Oxbryta can cause many serious and painful ...

• Depo-Provera: A Convenient Shot, But at What Cost to Women's ...

  https://www.drugwatch.com/featured/depo-provera-hidden-cost/
  Apr 7, 2025 ... But Depo remains available across the U.S. with no mention of a meningioma threat from manufacturer Pfizer or the Food and Drug Administration, ...